Hudson Vegas Investment SPV, LLC, together with Hudson Vegas Investment Manager, LLC and Daniel Straus, filed a Form 4 on August 12, 2026, disclosing the sale of all directly held Class A Common Stock of P3 Health Partners Inc. (NASDAQ:PIII) on August 10, 2026.

Key Highlights

  • Three separate sale tranches: 1,041 shares at a weighted average price of $13.38, 19,074 shares at $16.05, and 29,885 shares at $16.86, all on August 10, 2026.
  • Full position liquidated: Beneficial ownership of Class A Common Stock held directly by Hudson Vegas Investment SPV, LLC fell to 0 shares following the transactions.
  • Weighted average prices used: Each reported price reflects multiple transactions within stated ranges: $13.00-$13.61, $16.00-$16.24, and $16.25-$17.24, respectively.
  • Joint filing by three persons: Hudson Vegas Investment SPV, LLC, Hudson Vegas Investment Manager, LLC, and Daniel Straus filed the statement jointly.
  • 10% Owner relationship: All three reporting persons are identified as 10% owners of P3 Health Partners Inc.
  • Disclaimers noted: Hudson Vegas Investment Manager, LLC and Daniel Straus each disclaim beneficial ownership of any shares beyond their pecuniary interest therein.

Hudson Vegas Exits P3 Health Partners Class A Common Stock Position

According to the filing, Hudson Vegas Investment SPV, LLC disposed of a total of 50,000 shares of Class A Common Stock of P3 Health Partners Inc. across three transactions on August 10, 2026. The first tranche covered 1,041 shares sold at a weighted average price of $13.38, with individual transaction prices ranging from $13.00 to $13.61. The second tranche involved 19,074 shares at a weighted average of $16.05, with prices ranging from $16.00 to $16.24. The third tranche consisted of 29,885 shares at a weighted average of $16.86, with prices ranging from $16.25 to $17.24.

The filing indicates that all three sales carry transaction code "S," denoting open-market sales, and that all shares were directly owned. Following the completion of all three tranches, the filing reports that Hudson Vegas Investment SPV, LLC holds 0 shares of Class A Common Stock directly. The reporting persons noted they will provide full per-transaction pricing details upon request from the issuer, any security holder, or SEC staff.

The statement was filed jointly on behalf of Hudson Vegas Investment SPV, LLC, Hudson Vegas Investment Manager, LLC, and Daniel Straus, each of whom is listed as a 10% owner. The filing states that Hudson Vegas Investment SPV, LLC is the direct beneficial owner of the securities covered, while Hudson Vegas Investment Manager, LLC and Daniel Straus each may be deemed to share voting and dispositive power over shares held by the SPV. Both entities and Straus disclaim beneficial ownership beyond any pecuniary interest they may hold.

What Was Disclosed

The filing discloses three open-market sales of P3 Health Partners Class A Common Stock by Hudson Vegas Investment SPV, LLC on August 10, 2026, totaling 50,000 shares across weighted average prices ranging from $13.38 to $16.86, resulting in zero remaining direct beneficial ownership.